Navigation Links
Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
Date:4/10/2008

Company seeks to collaborate on latest research technologies

ALBUQUERQUE, N.M., April 10 /PRNewswire-FirstCall/ -- Researchers and executives from Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, will present a paper entitled "New Non-Invasive Technology for the Early Detection of Cancer at the Cellular Level" at the 83rd Annual Multidisciplinary Meeting of the American Association for the Advancement of Science (AAAS) Southwestern and Rocky Mountain (SWARM) Division, Thursday, April 10, in Albuquerque.

The paper will focus on Biomoda's non-invasive and cost-efficient screening technology for early detection of lung cancer. The technology, which was developed at Los Alamos National Laboratory, is based on a patented porphyrin molecule that preferentially binds to cancerous or aberrant cells extracted from the body as sputum, blood or urine. Cancerous or aberrant cells that bind porphyrin glow red under ultraviolet light; non-cancerous cells do not fluoresce.

Current diagnostic methods for lung cancer -- the leading cause of cancer-related deaths in the United States -- often detect the disease only at more advanced stages.

"This conference is an excellent venue for Biomoda to foster communication and share our research among other scientists and engineers," said John Cousins, Biomoda President. "We are excited about the opportunity to increase public understanding of our latest advances in in-vitro diagnostics for non-invasive testing for cancer at the cellular level."

Biomoda is seeking international partners interested in collaborating in the development and use of its non-invasive early-stage cancer detection technology.

Biomoda and the New Mexico Institute of Mining and Technology (New Mexico Tech) recently announced their partnership with the New Mexico Department of Veterans Services (DVS) to conduct a $350,000 clinical study using Biomoda's proprietary testing technology for detection of early lung cancer in the state's veterans. Biomoda will conduct the first year of the clinical program, while New Mexico Tech and DVS will oversee the study and provide treatment to those veterans who test positive for lung cancer.

The New Mexico state legislature recently allocated an additional $1.3 million in funding through the Interim Tobacco Settlement Committee to the clinical screening program.

Biomoda presenters at the SWARM conference include: Cousins; Leo S. Gomez, Ph.D., Director of Research; Constance J. Dorian, Director of Technical Operations; and Stephen M. Gomez, Ph.D., Senior Research Specialist.

For more information contact: John Cousins

Biomoda, Inc.

505-821-0875

verrityg@biomoda.com


'/>"/>
SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
3. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
6. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
7. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
8. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia
11. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... YORK , Feb. 11, 2016 ... instruments commonly used in laboratories. These may range from ... condensers. Laboratory glassware is made from borosilicate glass because ... Laboratory plasticware, on the other hand, started gaining popularity ... it was easier to replace glass with plastic in ...
(Date:2/11/2016)... , Feb. 11, 2016   Health 2.0 ... of new health technologies, announced today " 10 Year ... in health tech over the past ten years.   ... nearly a decade, Health 2.0 has served as the ... and connected with thousands of technologies, companies, innovators, and ...
(Date:2/11/2016)... AAIPharma Services Corp./Cambridge Major Laboratories, Inc. ... development services for the pharmaceutical and biotechnology industries, ... in its Charleston, SC ... recent investments. Charleston ... with small-scale lyophilization. The site has invested in ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... 2016 , ... According to an article published February 4th on ... portion of hernia repairs throughout the United States. Commenting on this article, Beverly Hills ... this trend has not only been expected, but it seems to be a natural ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills ... recruit top students from U.S. universities who will draw from Siemens’ deep ...
(Date:2/12/2016)... Church, VA (PRWEB) , ... February 12, 2016 ... ... Store?, Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... issue in the life cycle of pharmaceutical products, garnering increased attention from all ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... ... February 12, 2016 , ... Itopia, a ... the integration of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, migration and ... intelligence (BI) to their small and medium business (SMB) clients. , ...
Breaking Medicine News(10 mins):